22/05/2024

Beyond the audiogram: ACT™ is a new standard for speech-in-noise prescription

A dive into Prof. Jürgens talk “The Audible Contrast Threshold (ACTTM) test: a novel test to predict hearing-in-noise ability and guide hearing-aid fitting”

Reading time: 5 minutes

Audiology

Technology

View
alt
Showing all
17/09/2024

The impact of untreated hearing loss on healthy aging

In this BrainHearing™ Network webinar, we were thrilled to present an enlightening session with Dr. Dona Jayakody, head of Brain and Hearing at the Ear Science Institute Australia. Dr. Jayakody shared profound insights into the far-reaching impacts of untreated hearing loss on healthy aging.

Reading time: 5 minutes

Audiology

Hearing loss

View
alt
22/05/2024

Beyond the audiogram: ACT™ is a new standard for speech-in-noise prescription

A dive into Prof. Jürgens talk “The Audible Contrast Threshold (ACTTM) test: a novel test to predict hearing-in-noise ability and guide hearing-aid fitting”

Reading time: 5 minutes

Audiology

Technology

View
alt
31/01/2024

Understanding communication behaviour to provide intent-based personalisation

The launch of our new premium hearing aid Oticon Intent™ marked a significant step forward in understanding the user’s listening needs and communication intentions in order to seamlessly provide the brain with individualised hearing support in any situation.

Reading time: 5 minutes

Audiology

Hearing aids

View
alt
06/12/2023

The rewiring brain in hearing loss

6 December 2023 marked the launch of a new exciting Oticon initiative, the BrainHearing™ Network, with the aim of connecting scientists and hearing care professionals all around the world.

Reading time: 5 minutes

Audiology

Hearing loss

View
alt
oticon logo
  • About us
  • Contact us
  • Careers at Demant
  • Press center
  • Modern Slavery Statement
  • Carbon Reduction Plan Guidance
  • Privacy notice
  • Cookie policy
  • Declaration of conformity
  • Trademarks information
  • REACH

Select country

  • United Kingdom (english)
  • Facebook
  • Instagram
  • Linkedin